ArticleTransplantation direct2015

A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates.

Kentaro Ide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.